<\/p>\n
Kenacort-injektion<\/strong> is a sterile depot suspension from Abbott Healthcare containing triamcinolone acetonide<\/strong> p\u00e5 10 mg\/mL and 40 mg\/mL vials<\/strong>, supplied for intramuscular (IM) or intra-articular (IA) injection<\/strong>. Triamcinolone acetonide is highly insoluble — once injected it forms a microcrystalline depot that releases active drug slowly over 2–6 weeks<\/strong>, giving prolonged anti-inflammatory effect from a single injection. Common uses: intra-articular injection<\/strong> for knee, shoulder and small-joint inflammation in osteoarthritis or rheumatoid arthritis; intramuscular depot<\/strong> for severe seasonal allergic rhinitis, dermatologic flares, asthma exacerbations not requiring hospitalisation; intralesional injection<\/strong> for hypertrophic scars, keloids, alopecia areata, localised psoriasis. Joint-injection limits<\/strong>: no more than 3–4 injections per joint per year<\/strong>, no more than one injection every 3 months<\/strong> per joint — more frequent use accelerates cartilage damage. Local side effects include skin atrophy and depigmentation around the injection site, fat atrophy at IM sites, post-injection joint flare, and (rarely) septic arthritis. Systemic effects mimic oral steroids in proportion to the cumulative dose absorbed.<\/p>\n<\/div>\n <\/p>\n \ud83d\udce6 Varje best\u00e4llning omfattas av v\u00e5r Reshipment Assurance Policy<\/strong><\/a> \u2014 om din f\u00f6rs\u00e4ndelse inte anl\u00e4nder inom 20 arbetsdagar, skickar vi om den.<\/p>\n V\u00e5ra generiska l\u00e4kemedel kommer fr\u00e5n WHO-GMP-certifierade tillverkare och skickas v\u00e4rldsvidt i diskreta, enkla f\u00f6rpackningar \u2014 inget l\u00e4kemedelsnamn p\u00e5 f\u00f6rs\u00e4ndelsens utsida. Kortbetalningar hanteras via en reglerad betalningsprocessor (kontoutdrag visar en reglerad kortbetalningsprocessor \u2014 aldrig \u201cMedsBase\u201d eller n\u00e5got l\u00e4kemedelsnamn). Krypto och SEPA-bank\u00f6verf\u00f6ring accepteras ocks\u00e5. Varje best\u00e4llning backas upp av v\u00e5r Reshipment Assurance Policy.<\/p>\n Kenacort Injection is a depot suspension for intramuscular and intra-articular injection manufactured by Abbott Healthcare containing triamcinolone acetonide<\/strong> \u2014 en syntetisk kortikosteroid i glukokortikoidklassen. Glukokortikoider \u00e4r de mest kraftfulla bredspektruma antiinflammatoriska och immunsuppressiva l\u00e4kemedlen som finns, med effekter p\u00e5 n\u00e4stan alla v\u00e4vnader och organsystem.<\/p>\n Kenacort Injection is the original Indian-market injectable triamcinolone acetonide depot from Abbott Healthcare. The 10 mg\/mL strength<\/strong> is used for small-joint intra-articular injection and intralesional dermatology (alopecia, scars). The 40 mg\/mL strength<\/strong> is used for intramuscular depot, large-joint intra-articular (knee, shoulder) and high-dose intralesional treatment of keloid scars.<\/p>\n Triamcinolone 4 mg is approximately equivalent to prednisolone 5 mg (potency ratio ~5). The physiological daily cortisol output of a healthy adult is approximately 5–7.5 mg of prednisolone-equivalent — any dose above that is “supraphysiological” and begins to suppress the hypothalamic-pituitary-adrenal (HPA) axis.<\/p>\n Why a depot suspension?<\/strong> Triamcinolone acetonide is far less water-soluble than the sodium-phosphate or sodium-succinate esters used for IV steroids. Once injected, it forms microscopic crystals that dissolve over weeks, providing sustained low-dose glucocorticoid release without the daily-dosing burden of oral therapy. This is ideal for joint inflammation (where an injection inside the joint capsule keeps the drug locally concentrated), severe seasonal allergy (one IM injection covers most of the pollen season), and dermatology (localised intralesional injection of keloids, alopecia patches, hypertrophic scars).<\/p>\n Triamcinolone enters cells, binds the den intracellul\u00e4ra glukokortikoidreceptorn<\/strong>, och receptor-l\u00e4kemedelskomplexet transporteras till cellk\u00e4rnan d\u00e4r det \u00e4ndrar transkriptionen av hundratals gener. Slutresultatet \u00e4r en bred d\u00e4mpning av den inflammatoriska kaskaden:<\/p>\n Clinical onset (depot IM\/IA): noticeable improvement within 24\u201348 timmar<\/strong> for joint inflammation; peak effect at 7–14 days. Total duration of useful effect: 2–6 weeks<\/strong> (joint), 3\u20136 veckor<\/strong> (IM depot for allergic rhinitis), 2–3 months<\/strong> (intralesional in keloid scars).<\/p>\n Kenacort Injection is used wherever sustained local or systemic glucocorticoid effect is wanted from a single injection.<\/p>\n Kenacort Injection is inte<\/strong> appropriate for: routine first-line management of osteoarthritis (lifestyle, weight, physiotherapy and NSAIDs first), septic arthritis (steroid is contraindicated until infection cleared), spinal injection (has been associated with rare but devastating cord infarction — best avoided in favour of soluble preparations), or any joint that has been injected within the past 3 months.<\/p>\n Kenacort Injection is supplied at 10 mg\/mL and 40 mg\/mL vials<\/strong>. Dose depends entirely on the indication and the route — this is a specialist or trained-clinician procedure<\/strong>, not for self-administration.<\/p>\nVarf\u00f6r best\u00e4lla fr\u00e5n MedsBase<\/h3>\n
What Is Kenacort Injection?<\/h2>\n
How Does Kenacort Injection Work?<\/h2>\n
\n
Anv\u00e4ndningsomr\u00e5den och indikationer<\/h2>\n
Intra-articular (IA) injection — into a joint<\/h3>\n
\n
Intramuscular (IM) depot — gluteal injection<\/h3>\n
\n
Intralesional injection — into the lesion<\/h3>\n
\n
Kenacort Injection Dosage and How to Use<\/h2>\n
Typical adult doses by route and indication<\/h3>\n